Fact CheckerSign in

NCT05660148Recruiting

Influence of Resentment and Forgivingness on Quality of Life in People Living With HIV

Source: ClinicalTrials.gov · Last updated 28 May 2026

Brief summary (registry, in English)

Life stress is strongly associated with poor mental and physical health and its effects explain significant morbidity and mortality. Forgiveness is one of the factors that can influence the effects of stress on health. By definition, forgiveness is the release of negative feelings, emotions, and behaviors - and possibly the release of positive feelings - toward an offender. Numerous studies have shown that forgiveness is associated with several mental and physical health benefits. The literature argues that high levels of propensity to forgive (trait) predispose that person to experience forgiveness (state) more often. In other words, a stronger forgiving disposition is believed to increase the experience of forgiveness, which, in turn, mitigates the negative effects of stress. Forgiveness is therefore a coping style that can play a beneficial role in the stress-health relationship. Patients living with HIV (PLHIV) are patients particularly exposed to stress, not only because of their chronic pathology but also because of the stigma attached to this disease. Very few studies have studied the impact of forgiveness (state or trait) on the physical health of PLHIV and even fewer the impact of an intervention promoting the disposition to forgive. The objective of this prospective observational monocentric study is to show in a very secular country that forgiveness has an effect on well-being as well as on other health parameters.

Status (registry)
Recruiting
Study type
Observational
Enrollment
206 (estimated)
First submitted
13 Dec 2022
Start date
6 May 2024
Primary completion date
6 Nov 2026
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Diseases
HIV
NCT number
NCT05660148

What you commit to

  • Study type: Observational
  • Planned participants: 206
  • From 6 May 2024 to the primary completion date, 6 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Erratic follow-up (non-compliance, predictable move) or moribund patient
  • Illiterate or not speaking french

Who the study is looking for

  • Belonging to the PLHIV followed at the Amiens University Hospital, not likely to move within the year
  • Possibility of follow-up in teleconsultation (usual support of the service)
  • Benefiting from a social security scheme
  • Consent to participate in the research

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Amiens
Coordinator of this site? Confirm its status
AmiensFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.